Mar 08, 2017 - Merck & Co., Inc. (MRK) and partner Pfizer, Inc. (PFE) announced that the FDA has accepted its new drug applications (NDA) for ertugliflozin as a monotherapy as well as two fixed-dose combination tablets.
Mar 06, 2017 - The Zacks Analyst Blog Highlights: Mylan, Roche, AstraZeneca, Merck and Sanofi
Mar 06, 2017 - Companies like Merck (MRK) are awaiting key FDA decisions this month.
Mar 03, 2017 - Immune Design Corp (IMDZ) is scheduled to report fourth-quarter 2016 results after the market closes on Mar 7.
Mar 03, 2017 - Quite a few companies including AstraZeneca (AZN) provided pipeline/regulatory updates this week.
Mar 03, 2017 - Aduro BioTech, Inc. (ADRO) reported fourth-quarter 2016 loss of 44 cents per share, wider than the Zacks Consensus Estimate of a loss of 38 cents.
Mar 01, 2017 - M&As, Pipeline Catalysts to Drive Pharma Sector
Feb 27, 2017 - Pharma Industry Outlook - February/March 2017
Aug 05, 2016 - As Bristol-Myers (BMY) tanks, check out these other large cap pharma stocks.
Aug 05, 2016 - Shares of Bristol-Myers were falling in morning trade Friday after one of their drugs didn't reach the levels they were hoping for, while its rival Merck saw its shares climb as its competing drug was more successful in the same trial earlier this year.